skip to main content
Idioma:
Primo Advanced Search
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search prefilters
Busca Simples
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: Base de dados/Biblioteca: BioMedCentral Open Access database remover Base de dados/Biblioteca: DOAJ Directory of Open Access Journals remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
0.3-kb fragment containing the R-U5-5’leader sequence of Friend murine leukemia virus influences the level of protein expression from spliced mRNA
0.3-kb fragment containing the R-U5-5’leader sequence of Friend murine leukemia virus influences the level of protein expression from spliced mRNA
Material Type:
Artigo 		Adicionar ao Meu Espaço

0.3-kb fragment containing the R-U5-5’leader sequence of Friend murine leukemia virus influences the level of protein expression from spliced mRNA

Choo, Yeng Cheng ; Seki, Yohei ; Machinaga, Akihito ; Ogita, Nobuo ; Takase-Yoden, Sayaka

Virology journal, 2013-04, Vol.10 (1), p.124-124, Article 124 [Periódico revisado por pares]

England: Springer-Verlag

Texto completo disponível

Citações Citado por
2
06.04 Synergistic antitumor activity of pan-PI3K inhibition and immune checkpoint blockade in bladder cancer
06.04 Synergistic antitumor activity of pan-PI3K inhibition and immune checkpoint blockade in bladder cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

06.04 Synergistic antitumor activity of pan-PI3K inhibition and immune checkpoint blockade in bladder cancer

Pan, C ; Zhu, Z ; Zhu, S ; Ma, A ; Chittepu, VCSR ; Farrukh, H ; Cheng, F

Journal for immunotherapy of cancer, 2022-09, Vol.10 (Suppl 1), p.A2-A3 [Periódico revisado por pares]

London: BMJ Publishing Group Ltd

Texto completo disponível

Citações Citado por
3
0.75% ropivacaine may be a suitable drug in pregnant women undergoing urgent cesarean delivery during labor analgesia period
0.75% ropivacaine may be a suitable drug in pregnant women undergoing urgent cesarean delivery during labor analgesia period
Material Type:
Artigo 		Adicionar ao Meu Espaço

0.75% ropivacaine may be a suitable drug in pregnant women undergoing urgent cesarean delivery during labor analgesia period

Men, Xin ; Wang, Qian ; Dong, Jia-fu ; Chen, Pei ; Qiu, Xiao-xiao ; Han, Yin-qiu ; Wang, Wei-long ; Zhou, Jin ; Shou, Hong-yan ; Zhou, Zhen-feng

BMC anesthesiology, 2024-06, Vol.24 (1), p.1-9, Article 212 [Periódico revisado por pares]

London: BioMed Central Ltd

Texto completo disponível

Citações Citado por
4
08.03 MHJC-based large-scale screening of anti-tumor T cells in chronic lymphocytic leukemia reveals CD8+ T cells with specificity against the clonotypic B-cell receptor immunoglobulin
08.03 MHJC-based large-scale screening of anti-tumor T cells in chronic lymphocytic leukemia reveals CD8+ T cells with specificity against the clonotypic B-cell receptor immunoglobulin
Material Type:
Artigo 		Adicionar ao Meu Espaço

08.03 MHJC-based large-scale screening of anti-tumor T cells in chronic lymphocytic leukemia reveals CD8+ T cells with specificity against the clonotypic B-cell receptor immunoglobulin

Basavaraju, Y ; Vardi, A ; Agathangelidis, A ; Pedersen, NW ; Karypidou, M ; Schaap-Johansen, A ; Fylaktou, A ; Stavroyianni, N ; Iskas, M ; Anagnostopoulos, A ; Chatzidimitriou, A ; Marcatili, P ; Hadrup, SR ; Stamatopoulos, K

Journal for immunotherapy of cancer, 2022-09, Vol.10 (Suppl 1), p.A3-A3 [Periódico revisado por pares]

London: BMJ Publishing Group Ltd

Texto completo disponível

Citações Citado por
5
08SG2/OsBAK1 regulates grain size and number, and functions differently in Indica and Japonica backgrounds in rice
08SG2/OsBAK1 regulates grain size and number, and functions differently in Indica and Japonica backgrounds in rice
Material Type:
Artigo 		Adicionar ao Meu Espaço

08SG2/OsBAK1 regulates grain size and number, and functions differently in Indica and Japonica backgrounds in rice

Yuan, Hua ; Fan, Shijun ; Huang, Juan ; Zhan, Shijie ; Wang, Shifu ; Gao, Peng ; Chen, Weilan ; Tu, Bin ; Ma, Bingtian ; Wang, Yuping ; Qin, Peng ; Li, Shigui

Rice (New York, N.Y.), 2017-12, Vol.10 (1), p.25-25, Article 25 [Periódico revisado por pares]

New York: Springer US

Texto completo disponível

Citações Citado por
6
0.9% Sodium chloride solution versus Plasma-Lyte 148 versus compound sodium lacTate solution in children admitted to PICU—a randomized controlled trial (SPLYT-P): study protocol for an intravenous fluid therapy trial
0.9% Sodium chloride solution versus Plasma-Lyte 148 versus compound sodium lacTate solution in children admitted to PICU—a randomized controlled trial (SPLYT-P): study protocol for an intravenous fluid therapy trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

0.9% Sodium chloride solution versus Plasma-Lyte 148 versus compound sodium lacTate solution in children admitted to PICU—a randomized controlled trial (SPLYT-P): study protocol for an intravenous fluid therapy trial

Raman, Sainath ; Schibler, Andreas ; Marsney, Renate Le ; Trnka, Peter ; Kennedy, Melanie ; Mattke, Adrian ; Gibbons, Kristen ; Schlapbach, Luregn J

Current controlled trials in cardiovascular medicine, 2021-07, Vol.22 (1), p.427-427, Article 427 [Periódico revisado por pares]

London: BioMed Central Ltd

Texto completo disponível

Citações Citado por
7
09.01 Armoring anti-HER2 CAR-T cells with C-C-motive receptor 8 (CCR8) and a dominant negative TGF-b receptor (DNR) to enable efficacy in solid tumor models
09.01 Armoring anti-HER2 CAR-T cells with C-C-motive receptor 8 (CCR8) and a dominant negative TGF-b receptor (DNR) to enable efficacy in solid tumor models
Material Type:
Artigo 		Adicionar ao Meu Espaço

09.01 Armoring anti-HER2 CAR-T cells with C-C-motive receptor 8 (CCR8) and a dominant negative TGF-b receptor (DNR) to enable efficacy in solid tumor models

Strzalkowski, TJ ; Cadilha, BL ; Dalloul, I ; Manske, K ; Endres, S ; Kobold, S

Journal for immunotherapy of cancer, 2022-09, Vol.10 (Suppl 1), p.A3-A4 [Periódico revisado por pares]

London: BMJ Publishing Group Ltd

Texto completo disponível

Citações Citado por
8
09.02 Bispecific antibodies enable synthetic agonistic receptor T cell therapy in melanoma
09.02 Bispecific antibodies enable synthetic agonistic receptor T cell therapy in melanoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

09.02 Bispecific antibodies enable synthetic agonistic receptor T cell therapy in melanoma

Benmebarek, M ; Märkl, F ; Keyl, J ; Cadilha, B ; Geiger, M ; Karches, C ; Obeck, H ; Schwerdtfeger, M ; Briukhovetska, D ; Jobst, J ; Müller, PJ ; Seifert, M ; Grünmeier, R ; Thomas, M ; Marr, C ; Levesque, M ; Heppt, M ; Endres, S ; Klein, C ; Kobold, S

Journal for immunotherapy of cancer, 2022-09, Vol.10 (Suppl 1), p.A4-A5 [Periódico revisado por pares]

London: BMJ Publishing Group Ltd

Texto completo disponível

Citações Citado por
9
09.03 CD122-directed IL-2/anti-IL-2 complexes enhance abscopal responses to radiation combined with anti-PD-1
09.03 CD122-directed IL-2/anti-IL-2 complexes enhance abscopal responses to radiation combined with anti-PD-1
Material Type:
Artigo 		Adicionar ao Meu Espaço

09.03 CD122-directed IL-2/anti-IL-2 complexes enhance abscopal responses to radiation combined with anti-PD-1

Onyshchenko, K ; Luo, R ; Niedermann, G

Journal for immunotherapy of cancer, 2022-09, Vol.10 (Suppl 1), p.A5-A5 [Periódico revisado por pares]

London: BMJ Publishing Group Ltd

Texto completo disponível

Citações Citado por
10
09.04 Secondary resistance to immunotherapy is associated with death and de-differentiation of activated T cells
09.04 Secondary resistance to immunotherapy is associated with death and de-differentiation of activated T cells
Material Type:
Artigo 		Adicionar ao Meu Espaço

09.04 Secondary resistance to immunotherapy is associated with death and de-differentiation of activated T cells

Qing, C ; Ghorani, E ; Foster, K ; Amann, M ; Uddin, I ; Beattie, G ; Solomon, I ; Arce-Vargas, F ; Peggs, K ; Quezada, S

Journal for immunotherapy of cancer, 2022-09, Vol.10 (Suppl 1), p.A5-A6 [Periódico revisado por pares]

London: BMJ Publishing Group Ltd

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (105.129)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (107.128)
  2. Anais de Congresso  (10)
  3. Reports  (2)
  4. Resenhas  (1)
  5. Mais opções open sub menu

Assunto 

  1. Science & Technology  (95.695)
  2. Life Sciences & Biomedicine  (94.211)
  3. Humans  (49.745)
  4. Health Aspects  (30.817)
  5. Analysis  (28.429)
  6. Female  (26.277)
  7. Male  (22.585)
  8. Care And Treatment  (21.837)
  9. Genetic Aspects  (20.864)
  10. Animals  (19.527)
  11. Physiological Aspects  (16.930)
  12. Proteins  (16.379)
  13. Risk Factors  (15.973)
  14. Adult  (13.891)
  15. Patients  (13.869)
  16. Gene Expression  (13.515)
  17. Medical Research  (13.477)
  18. Middle Aged  (13.169)
  19. Genes  (12.447)
  20. Oncology  (12.318)
  21. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de1988  (7)
  2. 1988Até2000  (84)
  3. 2001Até2007  (1.766)
  4. 2008Até2015  (35.061)
  5. Após 2015  (70.225)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (107.136)
  2. Japonês  (12.729)
  3. Português  (205)
  4. Alemão  (106)
  5. Italiano  (41)
  6. Norueguês  (24)
  7. Chinês  (3)
  8. Galês  (1)
  9. Francês  (1)
  10. Sueco  (1)
  11. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.